相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
BIRC3 and BIRC5: multi-faceted inhibitors in cancer
Raffaele Frazzi
CELL AND BIOSCIENCE (2021)
Screening and identification of key genes in imatinib-resistant chronic myelogenous leukemia cells: a bioinformatics study
Hong Zhang et al.
HEMATOLOGY (2021)
Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy
Elena Maria Brozos-Vazquez et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Genotype-Fitness Maps of EGFR-Mutant Lung Adenocarcinoma Chart the Evolutionary Landscape of Resistance for Combination Therapy Optimization
Patrick O. Bolan et al.
CELL SYSTEMS (2020)
Lung Cancer 2020 Epidemiology, Etiology, and Prevention
Brett C. Bade et al.
CLINICS IN CHEST MEDICINE (2020)
Lung Cancer Screening Patient Selection and Implementation
Nina A. Thomas et al.
CLINICS IN CHEST MEDICINE (2020)
Targeting apoptosis in cancer therapy
Benedito A. Carneiro et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectives
Giulia Sartori et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
mRNAs, proteins and the emerging principles of gene expression control
Christopher Buccitelli et al.
NATURE REVIEWS GENETICS (2020)
Bisdemethoxycurcumin Enhances the Sensitivity of Non-small Cell Lung Cancer Cells to Icotinib via Dual Induction of Autophagy and Apoptosis
Min Xiang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
J. Gao et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Osteopontin as a multifaceted driver of bone metastasis and drug resistance
Xiaocong Pang et al.
PHARMACOLOGICAL RESEARCH (2019)
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy
Jordi Bertran-Alamillo et al.
NATURE COMMUNICATIONS (2019)
Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer
Tomomi Sanomachi et al.
ANTICANCER RESEARCH (2019)
Live and let die: epigenetic modifications of Survivin and Regucalcin in non-small cell lung cancer tissues contribute to malignancy
Doerte Nitschkowski et al.
CLINICAL EPIGENETICS (2019)
Mitotic slippage: an old tale with a new twist
Debottam Sinha et al.
CELL CYCLE (2019)
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
Zuan-Fu Lim et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Resistance to molecularly targeted therapy in non-small-cell lung cancer
Tetsuhiko Asao et al.
RESPIRATORY INVESTIGATION (2019)
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
Suhas V. Vasaikar et al.
NUCLEIC ACIDS RESEARCH (2018)
Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors
D. Westover et al.
ANNALS OF ONCOLOGY (2018)
GSCALite: a web server for gene set cancer analysis
Chun-Jie Liu et al.
BIOINFORMATICS (2018)
Perturbing mitosis for anti-cancer therapy: is cell death the only answer?
Manuel Haschka et al.
EMBO REPORTS (2018)
Diagnostic Value of the Survivin Autoantibody in Four Types of Malignancies
Yuting Xiu et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2018)
Survivin and autoimmunity; the ins and outs
Hamidreza Ebrahimiyan et al.
IMMUNOLOGY LETTERS (2018)
Identification of NMU as a potential gene conferring alectinib resistance in non-small cell lung cancer based on bioinformatics analyses
Shuangjie You et al.
GENE (2018)
Transcriptome sequencing identifies key pathways and genes involved in gastric adenocarcinoma
Wenhu Zhang et al.
MOLECULAR MEDICINE REPORTS (2018)
YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction
Chun-Hua Dai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Stem cell fate in cancer growth, progression and therapy resistance
Nikki K. Lytle et al.
NATURE REVIEWS CANCER (2018)
UHRF1: The key regulator of epigenetics and molecular target for cancer therapeutics
Harsimran Sidhu et al.
TUMOR BIOLOGY (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Understanding and targeting resistance mechanisms in NSCLC
Julia Rotow et al.
NATURE REVIEWS CANCER (2017)
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
Andras Lanczky et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer
Luc Girard et al.
CLINICAL CANCER RESEARCH (2016)
Mitotic catastrophe and cancer drug resistance: A link that must to be broken
Tatiana V. Denisenko et al.
DRUG RESISTANCE UPDATES (2016)
The Functional Repertoire of Survivin's Tails
Sally P. Wheatley
CELL CYCLE (2015)
NCBI GEO: archive for functional genomics data sets-update
Tanya Barrett et al.
NUCLEIC ACIDS RESEARCH (2013)
Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer
Abel Sanchez-Palencia et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function
David Warde-Farley et al.
NUCLEIC ACIDS RESEARCH (2010)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
分享论文
